3631 results for «558»
3631 results
Optimal timing of aspirin discontinuation: when early is too early?
20 May 2026 – From EuroPCR 2026
This session critically evaluates the optimal timing for aspirin discontinuation after PCI, discussing outcomes of aspirin-free strategies initiated within one month versus three months post-procedure. It considers differential effects of DAPT duration based on ACS presentation and bleeding risk, supported by meta-analyses and real-world data to...
Bifurcation PCI with complications - Part 1
20 May 2026 – From EuroPCR 2026
This session addresses complications encountered during bifurcation PCI through real-world cases involving stent dislodgement, entrapped guidewires, failed wiring techniques, and fractured devices. It highlights technical rescue maneuvers, the role of intravascular imaging, and long-term challenges encountered in managing complex bifurcation lesions to improve procedural success and...
Unusual complexities, uncommon complications and innovative solutions
20 May 2026 – From EuroPCR 2026
This session showcases innovative solutions to unusual complexities and rare complications in interventional cardiology. Through detailed case presentations, it examines ambiguous CTO management, giant coronary aneurysm complications post-PCI, and unforeseen issues arising from coronary atherectomy for calcified nodules.
Complex distal LM PCI challenges (trifurcations and more)
20 May 2026 – From EuroPCR 2026
Focusing on the intricacies of complex distal left main PCI, this session covers challenging trifurcation lesions and emergency interventions. It includes IVUS-guided approaches for trifurcation PCI, management of calcified left main trifurcations, and multidisciplinary team rescue strategies for unstable left main bifurcation disease.
Navigating the complexity of high bleeding risk
20 May 2026 – From EuroPCR 2026
Focusing on patients with high bleeding risk undergoing PCI, this session presents contemporary evidence on prevalence, procedural strategies with different stent types, antiplatelet therapy considerations including diabetic and sex-specific outcomes, and novel technologies such as sirolimus-coated balloons and machine learning models for restenosis prediction.
Ambiguous left main lesions: how to assess severity and make the right decision
21 May 2026 – From EuroPCR 2026
Addressing the complexities of ambiguous left main coronary lesions, this session elucidates the integration of physiology, intracoronary imaging, and CT scanning for comprehensive assessment. It highlights multimodality diagnostic strategies and decision-making frameworks to guide appropriate revascularization.
Reliability and application of angio-based physiology in daily work
20 May 2026 – From EuroPCR 2026
This session evaluates the reliability and clinical application of angiography-based physiological assessments in daily practice. Topics include comparisons of angiography-derived microvascular resistance and flow metrics with invasive methods, reproducibility of quantitative flow ratio (QFR), and its correlation with symptom burden and other imaging modalities.
Jon DeHaan Foundation Award & Michele Pighi Young Investigator Award
20 May 2026 – From EuroPCR 2026
The Jon DeHaan Foundation Award & Michele Pighi Young Investigator Award session celebrates outstanding contributions to cardiovascular research and innovation. It highlights achievements by emerging investigators, recognizing excellence that advances the field of cardiology and inspires future clinical and scientific endeavors.
Personalised Vascular Care Award - Ceremony
20 May 2026 – From EuroPCR 2026
The Personalised Vascular Care Award Ceremony celebrated outstanding achievements in the advancement of personalized vascular treatment approaches, recognizing leaders who have contributed significantly to improving patient outcomes in vascular care.
Welcome to EuroPCR 2026
19 May 2026 – From EuroPCR 2026
Welcome to EuroPCR 2026, the premier event for interventional cardiology professionals. This edition offers cutting-edge scientific presentations, live cases, and interactive sessions designed to advance knowledge and clinical practice in cardiovascular interventions.
Complication and bailout of TAVI
18 Feb 2023 – From PCR Tokyo Valves 2023
As TAVI is never risk-free, learn about bailout techniques to counter various complications. This session explores cases such as failure to release aortic stenosis after implantation of a self-expanding valve, retrieving a pigtail catheter straightener dropped into aorta and balloon rupture during TAVI.
Transcatheter edge-to-edge repair for challenging situations
19 Feb 2023 – From PCR Tokyo Valves 2023
Explore various innovative repairs repairs: MitraClip for degenerative regurgitation, TEER bridge therapy, successful combined MitraClip and TriClip procedure, and simultaneous mitral repair with LAA closure.
TAVI and alternative access
19 Feb 2023 – From PCR Tokyo Valves 2023
Learn more about TAVI in this session by reviewing case submissions on topics such as bailout transseptal approach, primary percutaneous transaxillary TAVI, and transapical TAVI with chimney stenting.
Challenging case in mitral valve intervention
19 Feb 2023 – From PCR Tokyo Valves 2023
Consult this session to discover challenging mitral valve cases. Learn to anticipate challenging anatomy, determine optimal timing for MitraClip, and witness changes in degenerative and functional mitral regurgitation procedures.
Selection of the 2023 best abstracts
19 Feb 2023 – From PCR Tokyo Valves 2023
Watch this session to discover the best cases and abstracts unveiled at PCR Tokyo Valves 2023, covering topics such as transcatheter aortic valve implantation impact, cerebral protection efficacy, and post-TAVI aortic regurgitation quantification.
Future perspectives of LAAC
17 Feb 2023 – From PCR Tokyo Valves 2023
In this session, delve into the evolving landscape of Left Atrial Appendage Closure (LAAC). Explore evidence, optimal patient criteria, and comprehensive preprocedural assessments for innovative LAAO devices.
The role and benefit of WATCHMAN FLX in stroke prevention
17 Feb 2023 – From PCR Tokyo Valves 2023
In this session, discover WATCHMAN FLX's numerous benefits for stroke prevention, covering topics such as patient indications for LAAC, the importance of Heart-Brain Team collaboration and post-procedural management insights.
PFO closure
17 Feb 2023 – From PCR Tokyo Valves 2023
Consult this session to learn procedural tips and tricks and explore the role of PFO treatment for stroke prevention. Discover the evidence for PFO closure, when it should be considered, pre, intra and post procederal management, and common procedural complications.
Expanding the spectrum of TEER suitability
18 Feb 2023 – From PCR Tokyo Valves 2023
Join this session to delve into diverse Transcatheter Edge-to-Edge Repair (TEER) scenarios, covering optimal patient groups for MitraClip therapy, insights from the EXPAND G4 study and the meticulous choice of four clip sizes for varying valve anatomies.
Technical challenges and optimal device choice for complex TAVI procedures
18 Feb 2023 – From PCR Tokyo Valves 2023
This session reflects on the importance of device choice and implantation technique in complex TAVI procedures. Uncover challenges in TAVI for failed bioprostheses and bicuspid aortic valves, emphasising optimal device selection and exploring the latest evolutions in TAVI such as the Medtronic.